| PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes VR Aroda, J Rosenstock, Y Terauchi, Y Altuntas, NM Lalic, ... Diabetes care 42 (9), 1724-1732, 2019 | 351 | 2019 |
| Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial TR Pieber, B Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, ... The lancet Diabetes & endocrinology 7 (7), 528-539, 2019 | 219 | 2019 |
| Genetic investigation of 100 heart genes in sudden unexplained death victims in a forensic setting SL Christiansen, CL Hertz, L Ferrero-Miliani, M Dahl, PE Weeke, ... European Journal of Human Genetics 24 (12), 1797-1802, 2016 | 82 | 2016 |
| Next-generation sequencing of 34 genes in sudden unexplained death victims in forensics and in patients with channelopathic cardiac diseases CL Hertz, SL Christiansen, L Ferrero-Miliani, SL Fordyce, M Dahl, ... International journal of legal medicine 129, 793-800, 2015 | 74 | 2015 |
| Genetic investigations of sudden unexpected deaths in infancy using next-generation sequencing of 100 genes associated with cardiac diseases CL Hertz, SL Christiansen, MK Larsen, M Dahl, L Ferrero-Miliani, ... European journal of human genetics 24 (6), 817-822, 2016 | 70 | 2016 |
| Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart CL Hertz, SL Christiansen, L Ferrero-Miliani, M Dahl, PE Weeke, LuCamp, ... International journal of legal medicine 130, 91-102, 2016 | 67 | 2016 |
| Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes RV Overgaard, CL Hertz, SH Ingwersen, A Navarria, DJ Drucker Cell Reports Medicine 2 (9), 2021 | 65 | 2021 |
| PIONEER 7 investigators. Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label … TR Pieber, B Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, ... Lancet Diabetes Endocrinol 7 (7), 528-539, 2019 | 33 | 2019 |
| Long-term efficacy and safety of oral semaglutide and the effect of switching from sitagliptin to oral semaglutide in patients with type 2 diabetes: a 52-week, randomized, open … JB Buse, BW Bode, A Mertens, YM Cho, E Christiansen, CL Hertz, ... BMJ Open Diabetes Research and Care 8 (2), e001649, 2020 | 28 | 2020 |
| A comparison of genetic findings in sudden cardiac death victims and cardiac patients: the importance of phenotypic classification CL Hertz, L Ferrero-Miliani, R Frank-Hansen, N Morling, H Bundgaard EP Europace 17 (3), 350-357, 2015 | 28 | 2015 |
| Personality in adults who were born very preterm CL Hertz, R Mathiasen, BM Hansen, EL Mortensen, G Greisen Plos one 8 (6), e66881, 2013 | 28 | 2013 |
| Effect and safety of oral semaglutide monotherapy in type 2 diabetes—PIONEER 1 trial VR Aroda, J Rosenstock, Y Terauchi, OLE Jeppesen, E Christiansen, ... Diabetes 67 (Supplement_1), 2018 | 21 | 2018 |
| Targeted molecular genetic testing in young sudden cardiac death victims from Western Denmark MK Larsen, SL Christiansen, CL Hertz, R Frank-Hansen, HK Jensen, ... International journal of legal medicine 134, 111-121, 2020 | 19 | 2020 |
| Oral Semaglutide Reduces HbA1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER … RE Pratley, MJ Crowley, M Gislum, CL Hertz, TB Jensen, K Khunti, ... Diabetes Therapy 12, 1099-1116, 2021 | 15 | 2021 |
| Efficacy and safety of oral semaglutide by baseline age in J apanese patients with type 2 diabetes: A subgroup analysis of the PIONEER 9 and 10 J apan trials Y Yamada, D Yabe, CL Hertz, H Horio, J Nakamura, AM Nielsen, Y Seino Diabetes, Obesity and Metabolism 24 (2), 321-326, 2022 | 11 | 2022 |
| Similar efficacy and gastrointestinal tolerability versus exposure for oral and subcutaneous semaglutide RV Overgaard, A Navarria, CL Hertz, SH Ingwersen Diabetologia 62 (Suppl 1), S375-S376, 2019 | 11 | 2019 |
| PIONEER 1 investigators. PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes VR Aroda, J Rosenstock, Y Terauchi, Y Altuntas, NM Lalic, ... Diabetes Care 42 (9), 1724-1732, 2019 | 10 | 2019 |
| 932-P: efficacy and safety of oral semaglutide by baseline age in the PIONEER clinical trial program VR Aroda, R Bauer, CL Hertz, E Montanya, R SØRRIG, ML Warren, ... Diabetes 69 (Supplement_1), 2020 | 8 | 2020 |
| Genetic investigations of 100 inherited cardiac disease-related genes in deceased individuals with schizophrenia SL Christiansen, JD Andersen, GE Themudo, CL Hertz, JR Busch, ... International Journal of Legal Medicine 135 (4), 1395-1405, 2021 | 5 | 2021 |
| Post-mortem investigation of young deceased individuals with ischemic heart disease—outcome of supplementary genetic testing for dyslipidemia CL Hertz, SL Christiansen, GL Ottesen, R Frank-Hansen, H Bundgaard, ... International journal of legal medicine 130, 947-948, 2016 | 5 | 2016 |
